The European Antibiotic Awareness Day 2023 emphasizes the importance of enhancing our understanding of antimicrobial resistance (AMR). AMR is a threat to humans, animals, plants and the environment, affecting us all. The Laboratory of Medical Microbiology takes this imminent threat very seriously and participates in several multi-country research projects that cover different aspects of AMR: NeoIPC studies resistant bacteria in neonatal intensive care units in Europe, MISTAR develops novel One Health interventions that will reduce the transmission of antibiotic resistant bacteria, the Global Point Prevalence Survey is a free tool for hospitals in all five continents to monitor antimicrobial use and resistance, while VALUE-Dx investigates the role of diagnostic tools in reducing antibiotic prescription. In addition, PEDICAP investigates impact of antibiotic therapy duration on severe community-acquired pneumonia, SNIP_AFRICA aims to implement all aspects of adaptive platform trials in neonatal sepsis from defining potential treatments of interest to translation into clinical guidance in Sub-Saharan Africa and AmReSu strengthens the innovation capacity in AMR surveillance in widening EU countries.

Head to our Projects webpage for more detailed information.